Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis.
about
Liver specific gene immunotherapies resolve immune suppressive ectopic lymphoid structures of liver metastases and prolong survival.Lipid-coated calcium phosphate nanoparticle and beyond: a versatile platform for drug delivery.Nanomaterials for cancer immunotherapy.Synergistic and low adverse effect cancer immunotherapy by immunogenic chemotherapy and locally expressed PD-L1 trap.
P2860
Investigation of phosphorylated adjuvants co-encapsulated with a model cancer peptide antigen for the treatment of colorectal cancer and liver metastasis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Investigation of phosphorylate ...... l cancer and liver metastasis.
@en
Investigation of phosphorylate ...... l cancer and liver metastasis.
@nl
type
label
Investigation of phosphorylate ...... l cancer and liver metastasis.
@en
Investigation of phosphorylate ...... l cancer and liver metastasis.
@nl
prefLabel
Investigation of phosphorylate ...... l cancer and liver metastasis.
@en
Investigation of phosphorylate ...... l cancer and liver metastasis.
@nl
P2860
P1433
P1476
Investigation of phosphorylate ...... al cancer and liver metastasis
@en
P2093
Leaf Huang
P2860
P304
P356
10.1016/J.VACCINE.2017.03.067
P407
P577
2017-04-03T00:00:00Z